The GLP-1R-cAMP pathway also decreases islet inflammation leading to better survival of β-cells (Pugazhenthi et al., 2010), and macrophage infiltration and inflammation of adipose tissue are inhibited by GLP-1 in an obese mouse model of diabetes (Lee et al., 2012). Here, GLP1R is linked to diabetes mellitus.